Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | CES1 | P23141 | 2/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | EP300 | Q09472 | 1/20 | 0.38 |
| ▸ | F7 | P08709 | 2/20 | 0.37 |
| ▸ | F3 | P13726 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.34 |
| ▸ | TERT | O14746 | 3/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.32 |
| ▸ | BLM | P54132 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | FABP4 | P15090 | 2/20 | 0.32 |
| ▸ | FAAH | O00519 | 2/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.32 |
| ▸ | PPARG | P37231 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29579491 | 0.97 | ALDH1A1 (0.38) | ALDH1A1TSHRCES1CES2EP300 | |
| SCHEMBL28088662 | 0.97 | ALDH1A1 (0.38) | ALDH1A1TSHRCES1CES2EP300 | |
| SCHEMBL27563971 | 0.93 | EP300 (0.43) | ALDH1A1TSHRCES1CES2EP300 | |
| SCHEMBL9230921 | 0.92 | CES2 (0.42) | CES1CES2EP300F7F3 | |
| Potassium Fluoride SCHEMBL27879454 | 0.91 | TSHR (0.33) | ALDH1A1TSHRCES1CES2EP300 | |
| SCHEMBL32675944 | 0.90 | EP300 (0.50) | TSHREP300F7F3TP53 | |
| SCHEMBL5679321 | 0.89 | TSHR (0.39) | ALDH1A1TSHRCES1CES2EP300 | |
| SCHEMBL31130683 | 0.89 | CES1 (0.39) | ALDH1A1TSHRCES1CES2EP300 | |
| SCHEMBL31528913 | 0.87 | ALDH1A1 (0.46) | ALDH1A1TSHRCES1CES2EP300 | |
| SCHEMBL29284350 | 0.87 | TSHR (0.52) | ALDH1A1TSHRCES1CES2EP300 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026043730-A1 | METHODS FOR PRODUCING AVIATION FUELS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2026-02-26 | — | — | WO | claimed |
| US-20260049256-A1 | METHODS FOR PRODUCING AVIATION FUELS | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2026-02-19 | — | — | US | claimed |
| CN-115394983-A | Amorphous alloy particle/porous carbon composite framework material, and preparation method and application thereof | 中国科学技术大学 | 2022-11-25 | — | — | CN | claimed |
| CN-111117136-B | Cable material | 温州大学 | 2022-06-07 | — | — | CN | claimed |
| CN-113527331-A | Nitroimidazole derivative and preparation method and application thereof | 南京长澳医药科技有限公司 | 2021-10-22 | — | — | CN | claimed |
| CN-109096249-B | Synthesis method of aripiprazole | 中国科学院兰州化学物理研究所 | 2021-04-09 | — | — | CN | claimed |
| CN-111117136-A | Cable material | 温州大学 | 2020-05-08 | — | — | CN | claimed |
| CN-110436842-A | A kind of cement mortar and preparation method thereof with electro-magnetic screen function | LIANG JIAN | 2019-11-12 | — | — | CN | claimed |
| CN-109718849-A | Inactivate the regeneration method of hetero-atom molecular-sieve and the application of regenerated molecular sieve | 中国石油化工股份有限公司 | 2019-05-07 | — | — | CN | claimed |
| CN-106279178-B | The fluorescence probe and synthetic method of Carbapenem-resistant class antibiotic germ and application | 华东理工大学 | 2019-01-18 | — | — | CN | claimed |
| CN-102015650-A | 2-aminoquinoline derivatives as 5-HT(5A) receptor antagonists | HOFFMANN LA ROCHE | 2011-04-13 | — | — | CN | claimed |
| CN-100480422-C | Method for processing low dielectric constant film using direct current bias | APPLIED MATERIALS INC (US) | 2009-04-22 | — | — | CN | claimed |
| CN-100427521-C | Novel polyfluorene derivative-polysilicofluorene and method for preparation thereof | UNIV FUDAN (CN) | 2008-10-22 | — | — | CN | claimed |
| US-20060173145-A1 | Multi-functionalized high-trans elastomeric polymers | BRIDGESTONE CORPORATION (JP) | 2006-08-03 | — | — | US | claimed |
| CN-1788108-A | Method for processing low dielectric constant film using direct current bias | APPLIED MATERIALS INC (US) | 2006-06-14 | — | — | CN | claimed |
| CN-1654496-A | Novel polyfluorene derivative-polysilicofluorene and method for preparation thereof | UNIV FUDAN (CN) | 2005-08-17 | — | — | CN | claimed |
| CN-1075072-C | Oxazolidinone derivs, their preparation and therapeutical use | SYNTHELABO (FR) | 2001-11-21 | — | — | CN | claimed |
| EP-0835254-B1 | OXAZOLIDINONE DERIVATIVES, THEIR PREPARATION AND THERAPEUTICAL USE | SYNTHELABO (FR) | 1999-09-01 | — | — | EP | claimed |
| US-5843975-A | Oxazolidinone derivatives, their preparation and therapeutical use | SYNTHELABO (FR) | 1998-12-01 | — | — | US | claimed |
| CN-1191534-A | oxazolidinone derivatives, their preparation and their medical use | SYNTHELABO (FR) | 1998-08-26 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060173145-A1 | Multi-functionalized high-trans elastomeric polymers | VCL, PUF60, JMJD6 | ALDH1A1 3595/4885TSHR 4359/4885CES1 3614/4885 |
| US-20260049256-A1 | METHODS FOR PRODUCING AVIATION FUELS | CYP4F8, CPT1A, CBR1 | ALDH1A1 902/4885TSHR 4431/4885CES1 553/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.